secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2023-01-27T23:59:59+00:00
Accession:  0001493152-23-002809
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Daré Bioscience amends bylaws to update stockholder nomination procedures and other governance provisions
--------------------------------------------------------------------------------

- Bylaws amended effective Jan 24, 2023 to update advance notice procedures for director nominations and stockholder proposals.
- Added requirement for stockholders to comply with Rule 14a-19; non-compliance renders nominees ineligible for election.
- Prohibits nominating more candidates than board seats; requires stockholder or representative to appear at meeting.
- Updated forum selection provision to require certain actions be brought in Delaware courts; stockholder consents to personal jurisdiction.
- Other amendments to conform to Delaware law and make administrative, clarifying, and modernizing changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315223002809/0001493152-23-002809-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315223002809/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-002809

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer